On Tuesday, American Federal health officials accused AstraZeneca of including “outdated information” and providing misleading data in touting the effectiveness of its COVID-19 vaccine in a U.S. study.
In response AstraZeneca said, it's working on recent findings and updated information. It also promised an update within 48 hours.
On Monday, AstraZeneca announced that its vaccine worked well in the US study. It announced that a study of 32,000 volunteers showed that vaccinated volunteers did not suffer hospitalizations and severe illness and it was 79% effective in preventing Covid-19 symptoms.
Soon after this announcement, an independent panel that supervises the study rebuked the company for outdated data, as per a senior administration official.
A statement was issued by the National Institutes of Health few hours after this announcement by AstraZeneca that says the study may have included outdated data from that trial and it may have provided incomplete view of the...